We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





Technopath Launches Multichem ID-COVID-19 Quality Control Solutions

By LabMedica International staff writers
Posted on 19 May 2020
Print article
Image: Multichem ID-Covid 19 Quality Controls (Photo courtesy of Technopath Clinical Diagnostics)
Image: Multichem ID-Covid 19 Quality Controls (Photo courtesy of Technopath Clinical Diagnostics)
Technopath Clinical Diagnostics (Tipperary, Ireland) has launched its Multichem ID-COVID-19 Quality Control Solutions which offer laboratories third-party quality control products, enabling an independent, unbiased assessment of a diagnostic device or method for COVID-19 antibody testing.

Triggered by a massive effort from the clinical diagnostic industry to introduce antibody tests worldwide, Technopath is responding to the urgent need from the laboratory community for third-party quality control solutions. The company’s Multichem COVID-19 (IgG, IgM and Neg) solutions are third-party quality control products that help provide an independent assessment of a diagnostic device or method for COVID-19 antibody testing. These controls are manufactured based on a human base matrix that helps provide a product analogous to a patient sample.

"We are firmly resolute in supporting the global response to the COVID-19 pandemic by manufacturing independent quality solutions helping diagnostic companies and laboratories get to optimal test performance as quickly as possible," said Malcolm Bell, CEO and founder of Technopath. "With some clinical labs processing up to 500,000 coronavirus antibody tests per month, the company is laser-focused on assuring the quality of patient testing, and we believe our third-party QC solutions will reduce potential errors allowing laboratories to release patient results with confidence."

"With antibody testing accelerating across nations, clinical laboratories should be demanding data on validation studies, sensitivity and specificity, and conducting those studies in their labs," said James O. Westgard, PhD, longtime leader in clinical laboratory quality-control and founder of Westgard QC. "Quality-control is one of the most critical aspects of laboratory testing, and laboratories need to be adding third-party controls to their methods as soon as possible."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS-CoV-2 RT-PCR Assay
Reliance SARS-CoV-2 RT-PCR Assay Kit

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.